Analysts Offer Predictions for HealthEquity FY2025 Earnings

HealthEquity, Inc. (NASDAQ:HQY) – Zacks Research lifted their FY2025 earnings per share (EPS) estimates for shares of HealthEquity in a note issued to investors on Monday, December 30th. Zacks Research analyst R. Department now anticipates that the company will post earnings of $2.30 per share for the year, up from their previous forecast of $2.25. The consensus estimate for HealthEquity’s current full-year earnings is $3.12 per share.

HQY has been the subject of several other research reports. BTIG Research boosted their price target on shares of HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a report on Thursday, November 14th. Bank of America lifted their target price on HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. Barrington Research raised their price target on shares of HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research note on Monday, December 2nd. Mizuho started coverage on shares of HealthEquity in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price target on the stock. Finally, The Goldman Sachs Group began coverage on HealthEquity in a report on Friday, November 15th. They set a “neutral” rating and a $108.00 target price on the stock. One investment analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $110.71.

HealthEquity Trading Up 0.9 %

NASDAQ HQY opened at $96.81 on Wednesday. HealthEquity has a 12 month low of $65.01 and a 12 month high of $105.82. The stock has a 50-day simple moving average of $96.69 and a 200 day simple moving average of $85.38. The company has a current ratio of 3.20, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51. The company has a market capitalization of $8.39 billion, a PE ratio of 88.82, a P/E/G ratio of 1.08 and a beta of 0.55.

Hedge Funds Weigh In On HealthEquity

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. International Assets Investment Management LLC acquired a new stake in shares of HealthEquity during the second quarter valued at about $35,000. Paladin Wealth LLC acquired a new stake in HealthEquity during the 3rd quarter worth approximately $39,000. Point72 Asia Singapore Pte. Ltd. bought a new stake in HealthEquity during the 2nd quarter worth approximately $73,000. GAMMA Investing LLC increased its position in HealthEquity by 57.8% in the 3rd quarter. GAMMA Investing LLC now owns 939 shares of the company’s stock valued at $77,000 after acquiring an additional 344 shares during the period. Finally, Quarry LP increased its position in HealthEquity by 418.8% in the 3rd quarter. Quarry LP now owns 1,349 shares of the company’s stock valued at $110,000 after acquiring an additional 1,089 shares during the period. Institutional investors own 99.55% of the company’s stock.

Insider Transactions at HealthEquity

In other HealthEquity news, Director Frank Corvino sold 1,039 shares of the company’s stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total transaction of $99,847.90. Following the completion of the sale, the director now directly owns 3,784 shares in the company, valued at $363,642.40. This represents a 21.54 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total value of $684,585.00. Following the completion of the transaction, the director now owns 54,719 shares in the company, valued at approximately $4,540,582.62. The trade was a 13.10 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 42,539 shares of company stock valued at $4,040,303. 2.20% of the stock is currently owned by company insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.